Table 1.
Clinical features of MDS patients (n = 10).
| Age, years (mean, range) | 72 (42–92) |
| Sex, males:females (n) | 5:5 |
| Hemoglobin (n) | |
| <10.0 g/dl | 7 |
| ≥10.0 g/dl | 3 |
| Neutrophil Count (n) | |
| <1.8 ×109/L | 4 |
| ≥1.8 ×109/L | 6 |
| Platelet Count (n) | |
| <100 ×109/L | 4 |
| ≥100 ×109/L | 6 |
| Transfusion Dependency (n) | |
| Yes | 5 |
| No | 5 |
| WHO Classification (n) | |
| AML secondary to MDS | 1 |
| MDS-RS-MLD | 1 |
| MDS-MLD | 2 |
| MDS-RS-SLD | 3 |
| MDS-SLD | 1 |
| MDS-EB-1 | 1 |
| MDS-EB-2 | 1 |
| Bone Marrow Fibrosis (n) | |
| Yes | 1 |
| No | 9 |
| Bone Marrow Blasts (n) | |
| <5% | 7 |
| ≥5 to <10% | 1 |
| ≥10% | 2 |
| IPSS Risk Score (n) | |
| Low | 6 |
| int-1 | 2 |
| High | 1 |
| IPSS-R Risk Score (n) | |
| Very low | 1 |
| Low | 6 |
| Int | 1 |
| Very high | 1 |
| Therapy at Blood Withdrawal | |
| Erythropoietin | 2 |